LILETTA |
PLAN B |
UPOSTELLE |
LEVONELLE ONE STEP |
LEVONELLE-2 |
ISTERANDA |
JADELLE |
PLAN B ONE-STEP |
OPCICON ONE-STEP |
LEVOSERT |
ATHENTIA NEXT |
MIRENA |
NORPLANT |
NORGESTREL (-)-FORM |
WY-5104 |
NORGESTON |
NORPLANT SYSTEM |
POSTINOR-2 |
NORPLANT II |
FALLBACK SOLO |
KYLEENA |
EZINELLE |
BAY86-5028 |
HER STYLE |
LEVONORGESTREL |
OVRETTE |
EMERRES UNA |
JAYDESS |
LEVONELLE |
EMERRES |
SKYLA |
MICROVAL |
(8R,9S,10R,13S,14S,17R)-13-ETHYL-17-ETHYNYL-17-HYDROXY- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- TETRADECAHYDROCYCLOPENTA[A] PHENANTHREN-3-ONE |
17-ETHYNYL-18-METHYL-19-NORTESTOSTERONE |
LÉVONORGESTREL |
18-METHYL-17-ALPHA-ETHYNYL-19-NORTESTOSTERONE |
18-METHYLNORETHISTERONE |
WY-3707 |
(-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17ALPHA-PREGN-4-EN-20-YN-3-ONE |
13-BETA-ETHYL-17ALPHA-ETHYNYL-17BETA-HYDROXYGON-4-EN-3-ONE |
MICROLUT |
13-ETHYL-17-ALPHA-ETHYNYLGON-4-EN-17-BETA-OL-3-ONE |
13-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXY-4-GONEN-3-ONE |
17ALPHA-ETHYNYL-13BETA-ETHYL-3-OXO-4-ESTREN-17BETA-OL |
LEVONORGESTRELUM |
17ALPHA-ETHYNYL-17-HYDROXY-18-METHYLESTR-4-EN-3-ONE |
POSTINOR |
D(-)-NORGESTREL |
LEVONOVA |
NORLEVO |
17ALPHA-ETHYNYL-18-HOMO-19-NORTESTOSTERONE |
MICROLUTON |
17-ALPHA-ETHINYL-13-BETA-ETHYL-17-BETA-HYDROXY-4-ESTREN-3-ONE |
17-ALPHA-ETHYNYL-13-ETHYL-19-NORTESTOSTERONE |
drugbank:00367 |
pubchem.compound:13109 |
chembl:CHEMBL1389 |
chemidplus:797-63-7 |
rxcui:6373 |
Drug Indications | for treatment of menopausal symptoms |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | contraceptive |
Drug Class | contraceptives |
Year of Approval | approved before 1982 |
inhibitor (inhibitory) |
Trial Name | AG-200-15 |
Novel drug target | Established target |
Trial Name | estradol/levonorgestrel,Menostar |
agonist (activating) |
binder |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Progesterone receptor agonist |
Trial Name | SOH-075,NorLevo |
other/unknown |
Trial Name | ethinyl estradiol + levonorgestrel,Seasonale, Lo Seasonale, Seasonique |
Novel drug target | Established target |
Trial Name | AG-200-15 |
LEVONORGESTREL | Primary Drug Name |
Year of Approval | approved before 1982 |
Drug Class | contraceptives |
Drug Indications | contraceptive |
Drug Class | Small Molecule |
FDA Approval | approved |
D0BA9U | TTD Drug ID |